Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. 1980

L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009661 Nortriptyline A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions. Desitriptyline,Desmethylamitriptylin,Allegron,Apo-Nortriptyline,Aventyl,Gen-Nortriptyline,Norfenazin,Nortrilen,Nortriptyline Hydrochloride,Novo-Nortriptyline,Nu-Nortriptyline,PMS-Nortriptyline,Pamelor,Paxtibi,ratio-Nortriptyline,Apo Nortriptyline,Gen Nortriptyline,Hydrochloride, Nortriptyline,Novo Nortriptyline,Nu Nortriptyline,PMS Nortriptyline,ratio Nortriptyline
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003647 Debrisoquin An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Debrisoquine,Tendor
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
August 1981, Clinical pharmacology and therapeutics,
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
March 1981, Lancet (London, England),
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
August 1983, Life sciences,
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
March 1980, British journal of clinical pharmacology,
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
September 1977, Lancet (London, England),
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
January 1981, Pharmacology,
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
January 1988, Cancer chemotherapy and pharmacology,
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
June 1992, Xenobiotica; the fate of foreign compounds in biological systems,
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
April 1979, British journal of clinical pharmacology,
L Bertilsson, and M Eichelbaum, and B Mellström, and J Säwe, and H U Schulz, and F Sjöqvist
October 1976, Psychopharmacology,
Copied contents to your clipboard!